Speculative company that produces ‘bionic eyes.’ It has multiple growth avenues in front of it and much of the hard work is already behind them. However, for investors there remain considerable financial risks. Source: First Look At Second Sight – Second Sight Medical Products (NASDAQ:EYES) | Seeking Alpha
Entries Tagged as 'EYES'
March 31st, 2018 · Comments Off on First Look At Second Sight